Morgan Yost, DO
Facial Plastic Surgery · Pocatello, IDNPI 1639485246
Payments from drug & device makers
Across 25 payments — averaging $29.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$186
- Acclarent, Inc$116
- GSK$97
- Harmony Biosciences LLC$51
- Intersect ENT, Inc.$46
- Pacira Pharmaceuticals Incorporated$31
- plus $204 from 10 others
What the payments were for
- Consulting fees$15021%
- Food & beverage$58179%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 2 | $186 |
| Acclarent, Inc | 2 | $116 |
| GSK | 2 | $97 |
| Harmony Biosciences LLC | 3 | $51 |
| Intersect ENT, Inc. | 3 | $46 |
| Pacira Pharmaceuticals Incorporated | 2 | $31 |
| Bristol Myers Squibb | 2 | $31 |
| Baxter Healthcare | 1 | $26 |
| Jazz Pharmaceuticals Inc. | 1 | $26 |
| Eisai Inc. | 1 | $22 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| EMD Serono, Inc. | 1 | $19 |
| Optinose US, Inc. | 1 | $17 |
| Aerin Medical Inc. | 1 | $16 |
| Hikma Pharmaceuticals USA | 1 | $14 |
| Stryker | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TruDi Nav Cable$104
How this compares
Too few facial plastic surgery providers in Idahoto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Azelastine Hcl | 208 | $3,025 |
| Fluticasone Propionate | 196 | $1,567 |
| Ipratropium Bromide | 36 | $974 |
| Famotidine | 132 | $452 |
| Omeprazole | 106 | $384 |
| Fluocinolone Acetonide Oil | 17 | $273 |
| Mupirocin | 47 | $263 |
| Doxycycline Hyclate | 15 | $252 |
| Cephalexin | 24 | $160 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 13 | $157 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 15 | $45 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Pocatello
- Bret RodgersBoise$353
- Alan GrayEagle$269
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.